Hiroshi Kunikane

1.6k total citations
57 papers, 1.2k citations indexed

About

Hiroshi Kunikane is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hiroshi Kunikane has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 23 papers in Molecular Biology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hiroshi Kunikane's work include Cancer therapeutics and mechanisms (13 papers), Lung Cancer Research Studies (12 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Hiroshi Kunikane is often cited by papers focused on Cancer therapeutics and mechanisms (13 papers), Lung Cancer Research Studies (12 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Hiroshi Kunikane collaborates with scholars based in Japan, United States and United Kingdom. Hiroshi Kunikane's co-authors include Hiroaki Okamoto, Koshiro Watanabe, Nagahiro Saijo, Akira Yokoyama, Hideo Kunitoh, Shosaku Abe, Yoshikazu Kawakami, Tomohiro Tamura, Katsumi Eguchi and Kenji Eguchi and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Hiroshi Kunikane

57 papers receiving 1.2k citations

Peers

Hiroshi Kunikane
Hiroshi Kunikane
Citations per year, relative to Hiroshi Kunikane Hiroshi Kunikane (= 1×) peers Hangjun Wang

Countries citing papers authored by Hiroshi Kunikane

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Kunikane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Kunikane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Kunikane more than expected).

Fields of papers citing papers by Hiroshi Kunikane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Kunikane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Kunikane. The network helps show where Hiroshi Kunikane may publish in the future.

Co-authorship network of co-authors of Hiroshi Kunikane

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Kunikane. A scholar is included among the top collaborators of Hiroshi Kunikane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Kunikane. Hiroshi Kunikane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Katakami, Nobuyuki, Hiroshi Kunikane, Koji Takeda, et al.. (2014). Prospective Study on the Incidence of Bone Metastasis (BM) and Skeletal-Related Events (SREs) in Patients (pts) with Stage IIIB and IV Lung Cancer—CSP-HOR 13. Journal of Thoracic Oncology. 9(2). 231–238. 49 indexed citations
2.
Naoki, Katsuhiko, et al.. (2009). Dose-escalating and Pharmacokinetic Study of a Weekly Combination of Paclitaxel and Carboplatin for Inoperable Non-small Cell Lung Cancer: JCOG 9910-DI. Japanese Journal of Clinical Oncology. 39(9). 569–575. 5 indexed citations
3.
Yamamoto, Nobuyuki, Toshiaki Takahashi, Hiroshi Kunikane, et al.. (2008). Phase I/II Pharmacokinetic and Pharmacogenomic Study of UGT1A1 Polymorphism in Elderly Patients With Advanced Non–Small Cell Lung Cancer Treated With Irinotecan. Clinical Pharmacology & Therapeutics. 85(2). 149–154. 35 indexed citations
4.
Okamoto, Hiroaki, Kenji Watanabe, Hiroshi Kunikane, et al.. (2007). Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702. British Journal of Cancer. 97(2). 162–169. 148 indexed citations
5.
Narita, Yusuke, et al.. (2007). [A case of legionella pneumonia associated with acute respiratory distress syndrome (ARDS) and acute renal failure treated with methylprednisolone and sivelestat].. PubMed. 45(5). 413–8. 8 indexed citations
6.
Okamoto, Hiroaki, et al.. (2006). Transbronchial needle aspiration cytology of subcarinal lymph nodes for the staging procedure in the diagnosis of lung cancer. Respirology. 11(6). 782–785. 3 indexed citations
7.
Okamoto, Hiroaki, Katsuhiko Naoki, Yusuke Narita, et al.. (2006). A combination chemotherapy of carboplatin and irinotecan with granulocyte colony-stimulating factor (G-CSF) support in elderly patients with small cell lung cancer. Lung Cancer. 53(2). 197–203. 18 indexed citations
8.
Kunitoh, Hideo, Hirotaka Okamoto, Kiichi Watanabe, et al.. (2005). 広範囲疾患小細胞肺癌(ED‐SCLC)の高齢又は予後不良患者におけるカルボプラチン(Cb)又はエトポシド(E)とシスプラチン(P)との多剤併用無作為第III相試験:日本臨床腫瘍学グループ治験報告(JCOG9702). Lung Cancer. 49. 53. 2 indexed citations
9.
Ramachandran, Cheppail, Hiroshi Kunikane, Wei You, & Awtar Krishan. (1998). Phorbol ester-induced P-glycoprotein phosphorylation and functionality in the HTB-123 human breast cancer cell line. Biochemical Pharmacology. 56(6). 709–718. 13 indexed citations
11.
Inomata, Motoko, Nagahiro Saijo, Kazuko Kawashima, et al.. (1995). Induction of apoptosis in cultured retinoblastoma cells by the protein phosphatase inhibitor, okadaic acid. Journal of Cancer Research and Clinical Oncology. 121(12). 729–738. 21 indexed citations
12.
Kubota, Naohiro, Kazuto Nishio, Yuichiro Takeda, et al.. (1994). Characterization of an etoposide-resistant human ovarian cancer cell line. Cancer Chemotherapy and Pharmacology. 34(3). 183–190. 10 indexed citations
13.
Ohmatsu, H., Tomohide Tamura, Hiroshi Kunikane, et al.. (1994). A Randomized Cross‐over Study of High‐dose Metoclopramide plus Dexamethasone versus Granisetron plus Dexamethasone in Patients Receiving Chemotherapy with High‐dose Cisplatin. Japanese Journal of Cancer Research. 85(11). 1151–1158. 14 indexed citations
14.
Tamura, Tomohide, Yasutsuna Sasaki, Kenji Eguchi, et al.. (1994). Phase I and Pharmacokinetic Study of Paclitaxel by 24‐Hour Intravenous Infusion. Japanese Journal of Cancer Research. 85(10). 1057–1062. 17 indexed citations
15.
Ohira, Tatsuo, Yuichiro Ohe, Yuji Heike, et al.. (1994). In vitro and in vivo growth of B16F10 melanoma cells transfected with interleukin-4 cDNA and gene therapy with the transfectant. Journal of Cancer Research and Clinical Oncology. 120(11). 631–635. 21 indexed citations
16.
Ogura, Shigeaki, Shosaku Abe, Noriaki Sukoh, et al.. (1992). Correlation between nucleolar organizer regions visualized by silver staining and the growth rate in lung adenocarcinoma. Cancer. 70(1). 63–68. 27 indexed citations
17.
Okamoto, Hiroaki, Nagahiro Saijo, Tetsu Shinkai, et al.. (1992). Chemotherapy-induced anemia in patients with primary lung cancer. Annals of Oncology. 3(10). 819–824. 25 indexed citations
18.
Kunikane, Hiroshi, et al.. (1991). Pulmonary Nontuberculous Mycobacteriosis Showing Wandering Shadows in Chest Roentgenograms. Respiration. 58(5-6). 321–323. 3 indexed citations
19.
Abe, Shosaku, et al.. (1991). Nucleolar organizer regions in precancerous and cancerous lesions of the bronchus. Cancer. 67(2). 472–475. 22 indexed citations
20.
Abe, Shosaku, et al.. (1987). Association of HLA-DR with Sarcoidosis. CHEST Journal. 92(3). 488–490. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026